Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses

Analyst Ritu Baral from TD Cowen maintained a Buy rating on Amicus (FOLD – Research Report) and keeping the price target at $20.00.

Ritu Baral has given her Buy rating due to a combination of factors that highlight Amicus’s strategic positioning and future growth potential. Despite the first quarter revenue misses for both PomOp and Galafold, which were impacted by higher UK VPAG rebates, the company has maintained a positive outlook for GAAP profitability in the second half of 2025. This suggests confidence in the company’s ability to manage costs and drive future profitability.
Additionally, Amicus’s pipeline expansion, particularly with the in-licensing of DMX-200 for FSGS, indicates a commitment to broadening its product offerings and enhancing long-term growth prospects. The company’s strategic moves, including plans for new US PomOp manufacturing, further support the potential for revenue growth and market expansion. These factors collectively underpin Ritu Baral’s Buy rating, reflecting optimism about Amicus’s future performance and strategic initiatives.

In another report released on April 17, Bank of America Securities also reiterated a Buy rating on the stock with a $14.00 price target.